Related references
Note: Only part of the references are listed.Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy
Hua Huang et al.
NANO LETTERS (2019)
Immunomodulatory Nanosystems
Xiangru Feng et al.
ADVANCED SCIENCE (2019)
Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages
Emeric Limagne et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Tumor microenvironment-responsive docetaxel-loaded micelle combats metastatic breast cancer
Tianqun Lang et al.
SCIENCE BULLETIN (2019)
Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy
Jinrong Peng et al.
ADVANCED SCIENCE (2018)
Emerging Functions of Regulatory T Cells in Tissue Homeostasis
Amit Sharma et al.
FRONTIERS IN IMMUNOLOGY (2018)
Identification and functional analysis of heterogeneous FOXP3+ Treg cell subpopulations in human pancreatic ductal adenocarcinoma
Gang Yi et al.
SCIENCE BULLETIN (2018)
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
Jianqin Lu et al.
NATURE COMMUNICATIONS (2017)
Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency
Miao Kong et al.
THERANOSTICS (2017)
Critical role of immunogenic cell death in cancer therapy
Tian Xia
SCIENCE BULLETIN (2017)
Reduction-Responsive Polypeptide Micelles for Intracellular Delivery of Antineoplastic Agent
Weiguo Xu et al.
BIOMACROMOLECULES (2017)
Sequentially Responsive Shell-Stacked Nanoparticles for Deep Penetration into Solid Tumors
Jinjin Chen et al.
ADVANCED MATERIALS (2017)
Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors
Yanqi Ye et al.
ACS NANO (2016)
Immune suppressive mechanisms in the tumor microenvironment
David H. Munn et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor
Yanli Li et al.
ACS NANO (2015)
Versatile preparation of intracellular-acidity-sensitive oxime-linked polysaccharide-doxorubicin conjugate for malignancy therapeutic
Weiguo Xu et al.
BIOMATERIALS (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Rikke B. Holmgaard et al.
CELL REPORTS (2015)
Targeting the indoleamine 2,3-dioxygenase pathway in cancer
Yong Wha Moon et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Sonochemical Fabrication of Dual-Targeted Redox-Responsive Smart Microcarriers
Zhanfeng Li et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Biocompatible reduction-responsive polypeptide micelles as nanocarriers for enhanced chemotherapy efficacy in vitro
Jianxun Ding et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
Giovanna Schiavoni et al.
CANCER RESEARCH (2011)
One-step preparation of reduction-responsive poly(ethylene glycol)-poly (amino acid)s nanogels as efficient intracellular drug delivery platforms
Jianxun Ding et al.
POLYMER CHEMISTRY (2011)
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
Rupal Ramakrishnan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors
Holly K. Koblish et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
Mark P. Chao et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
TGF-β and 'Adaptive' Foxp3+ Regulatory T cells
WanJun Chen et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2010)
IDO recruits Tregs in melanoma
George C. Prendergast et al.
CELL CYCLE (2009)
The critical contribution of TGF-β to the induction of Foxp3 expression and regulatory T cell function
Ethan M. Shevach et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
The immunoregulatory role of IDO-producing human dendritic cells revisited
P Terness et al.
TRENDS IN IMMUNOLOGY (2006)
Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells
A Okamoto et al.
CLINICAL CANCER RESEARCH (2005)
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
ML Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Share Paper
